RxDoctor Payments Data

Daniel Ohngemach

Vascular & Interventional Radiology · Stony Brook, NYNPI 1962898262

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (43.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Boston Scientific at 34.9% of the total. Reporting peaked in 2023 at $9,704 and has fallen 55.7% since, to $4,300 in 2025.

$16,739in general payments, 2019–2025

Across 114 payments — averaging $146.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$6K
  • Inari Medical, Inc.$4K
  • Trisalus Life Sciences, Inc.$4K
  • Histosonics, Inc.$961
  • Stryker$462
  • Penumbra, Inc.$225
  • plus $449 from 7 others
$11,258in research payments, 2019–2025

Across 6 payments — averaging $1876.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Inari Medical, Inc.$11K

What the payments were for

  • Speaking & faculty fees$3,27320%
  • Travel & lodging$6,27037%
  • Food & beverage$7,19743%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,739 in reported general payments places this provider in the 80th percentile of 306 vascular & interventional radiology providers in New York.

See all vascular & interventional radiology providers in New York

Medicare billing

Part B allowed, 2024
$87,857
Medicare patients
234
Services billed
613

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Stony Brook

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →